Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why does TDA STILL have O/S at 18.43M?? We know from other sources that, in light of the dumping/conversion activities in Feb and early March, that the O/S is something like 38-40M. That should have been updated a week or more ago (I wanna say by the 5th of each month?). I think otcmarkets.com has it right (or did as of about a week ago)...
+100. So very sad because this company has such IMMENSE potential—but that potential is being undermanaged and undercapitalized upon IN THE EXTREME.
And even if it can’t be simple and direct (complex thinking is a GOOD thing), the execution and messaging around it must be CLEAR AND CONSISTENT. They have HUGE problems with that...
“Appears to be” blah blah blah. Adding MORE issues to the equation? How about cultivating FULLY one or two in order to generate self-sustaining revenues? Ockham’s razor: simple, clear, and direct. UNREAL!
Two tried but true adages come to mind: “Pride goeth before the fall” (clearly, all evidence to the contrary notwithstanding, they continue to employ the “we got this” mindset—they don’t need anyone’s help or input) AND “For lack of vision (from their leaders) the people perish.” Roughly 1/4 of the way through this year—which is looking sadly similar to QQ3-4 of 2018 and all of 2019...
What does this have to do AT ALL with CMTH and CELZ?
And what do you make of their assertion that management could take the company private and leave the shareholders high and dry?
Makes complete sense—in THEORY—but operationalizing it is the real challenge (and that word may not be strong enough). Take CELZ: 2 years ago we learn of a procedure that should revolutionize ED treatment, a contract with Russia, and the involvement of global gurus in the ED space. These factors alone should have launched this upwards to stay (to say nothing of StemSpine and Amniostem). So why didn’t they have that effect, and how would “technical analysis” have helped to predict what DID occur?
Explain to me the TRUE value of traditional technical analysis in this case, when some stocks WITH revenues (like this one) have traded recently in microfractions of a cent, while others in the same sector trade in dollars with ZERO revenues—thereby rendering valuation HUGELY speculative (even more so than on the big exchanges). What is the TRUE value of technical analysis in this context?
But the public float is only about 725M
Interesting concept. What are the legal mechanisms involved in that maneuver? In other words, how do the shareholders get nothing, BK is NOT declared, and they just declare themselves private as of a certain date: how is that even legal?
CMTH is the company for which CELZ is the ticker. CMTH is itself a subsidiary
I predicted upwards of 40M shares—we’re at 38M...
“Over the target” doesn’t even BEGIN to capture it: in 2+ years I’ve gotten quite good at studying these personalities and players (their patterned behavior is highly predictable):
https://www.otcmarkets.com/stock/CELZ/security
The management of CMTH is the one with no credibility: we’ve been devastated by (1) GLACIAL “progress” on the publication of trial results, (2) virtual silence with respect to communications (and what IS released is so generic and devoid of meaty substance as to be practically useless—and the market responds accordingly), and (3) a 1:150 R/S, made necessary by (1) above. P.S. CMTH/CELZ are mentioned NOWHERE near serious stem cell discussionss—where real players are trading in dollars...
Whatever the run is, divide by 150. All this talk of parties and mortgage payoffs was rampant here 2 years ago. Once bitten...
Most of us DID average down—but then we got “divided down” by 150
I don’t need a dollar to break even—but I need multiple dollars to make up for the devastating damage done by them reducing my share count by a 1:150 factor!
+100. It needs to go to $15-20 for me truly to feel whole.
WTF: TDA now showing 2.76B OS (after couple weeks with celzd at ~18M OS)?!?! When CELZ ticker was reactivated on Friday of last week, it also showed ~18M OS intraday. Did they seriously just dump multiple billions of shares within a month’s time?
The same CEO said they were (presumably realistically) working toward financial self-sufficiency (through revenues) in 2019: how’d that play out?
How many OS now—25M, 30M, 40M? Average volume over the last 10 days is 1M...
Current PPS -70% POST R/S. Strong work Don and Tim: thanks for growing shareholder value=Time Magazine execs of the year. Move over, Jack Welch!
I wish I shared your optimism. All I see is my shares CUT by a factor of 150–AFTER which the PPS has fallen 50+% more! NOTHING has changed for @CMTH_Inc. A “second wave” of $celz investors has already lost 2/3 of its post-R/S share equity. No worries—we’re $celzd for now. No biggie that the same erratic, vacuous PRs are resulting in a continued free-fall: life couldn’t be better. NO CONFIDENCE...
Sage wisdom: “When someone shows you repeatedly that they don’t care about you, BELIEVE THEM.”
FYI: the “second class” of $celz $celzd investors (particularly those who started buying for the first time AFTER the R/S) have now lost 50-65% of their shares’ value. And the beat goes on...
+100. 2+ years’ worth of experience validate your every word: color me an empiricist!
R/S, we were told, was primarily needed to regain QB status. Now we are teetering perilously close to the bottom threshold required by that exchange—so...
Looks like more massive conversions taking place (pre-R/S equivalent of 55M shares traded in first 20mins).
I operate on the premise of “trust but verify”: since there has been so little to verify over the last 2+ years, there is NO TRUST.
Again, CMTH is nowhere near even the fringe discussions at the edges of stem cell conversations—the central players in which are trading in dollars (not R/S-engineered fractions of a cent)...
?So Tim’s doing $celz $celzd “a favor” by taking shares as pay? Until and only AFTER his “management consulting services” result in dramatic increases to OBJECTIVE shareholder value, he should CANCEL from the O/S whatever # of shares he would receive: show me PROOF of HIS value to us.?
Highest volume day since I’ve been onboard (2+ years)—we had a 250M day in Q4 of 2019. Multiply today’s volume by 150 and today’s was higher
At this rate, we MAY see something worth mentioning in about 5-10 years. Bottom line: CMTH and CELZ are NOWHERE near the discussions of “major players” in the stem cell space—some of whom are household names and ALREADY trading in dollars.